ipriflavone has been researched along with Laryngeal Neoplasms in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrandina, G | 1 |
| Almadori, G | 1 |
| Maggiano, N | 1 |
| Lanza, P | 1 |
| Ferlini, C | 1 |
| Cattani, P | 1 |
| Piantelli, M | 1 |
| Scambia, G | 1 |
| Ranelletti, FO | 1 |
1 other study available for ipriflavone and Laryngeal Neoplasms
| Article | Year |
|---|---|
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Estradiol; Humans | 1998 |